Mon, October 25, 2021

Raghuram Selvaraju Maintained (BBIO) at Strong Buy with Increased Target to $88 on, Oct 25th, 2021

Raghuram Selvaraju of HC Wainwright & Co., Maintained "BridgeBio Pharma, Inc." (BBIO) at Strong Buy with Increased Target from $87 to $88 on, Oct 25th, 2021.

Raghuram has made no other calls on BBIO in the last 4 months.



There are 2 other peers that have a rating on BBIO. Out of the 2 peers that are also analyzing BBIO, 0 agree with Raghuram's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Raghuram


  • Mani Foroohar of "SVB Leerink" Maintained at Buy with Increased Target to $68 on, Monday, October 4th, 2021
  • Geoff Meacham of "B of A Securities" Upgraded from Hold to Strong Buy and Held Target at $75 on, Friday, September 10th, 2021